发明名称 New FK-506 cytosolic binding protein
摘要 A new homogeneous cytosolic binding (HCB) protein, having a specific binding activity of about 26 mu g FK-506 per mg protein and a molecular weight of about 10-12 kilodaltons, reversibly binds the immunosuppressant FK-506 but not cyclosporine A (CSA). The protein is stable to heating at 56 degrees C. for 30 minutes retaining its FK-506 binding affinity, and has the (partial) amino terminal amino acid sequence: H2N G y V l G n V l G u T r I e S r P o G y A p G y A g T r P e P o L s A g-Gly-Gln-Thr-X-Val-Val-Val-His-Tyr-Thr-Gly-Met-Leu-Glu-Asp-Fly-Lys-Ph e-ASp (wherein X is undefined). The HCBV protein is isolated from the cytosol of mammalian tissues, preferably human neoplastic T-cell lines, e.g. Jurkat, and can be used in diagnostic and purification procedures involving FK-506 macrolide type immunosuppressants. The HCB protein also catalyses the cis-trans isomerization of proline-containing peptide bonds.
申请公布号 US5196352(A) 申请公布日期 1993.03.23
申请号 US19910722066 申请日期 1991.06.27
申请人 MERCK & CO., INC. 发明人 SIEKIERKA, JOHN J.;HUNG, HSUEN-YUN;STARUCH, MARIE J.;SIGAL, NOLAN H.;MUMFORD, RICHARD A.
分类号 C12N9/90;C12N15/90 主分类号 C12N9/90
代理机构 代理人
主权项
地址